noscript

News and Announcements

OncoSil Medical to Attend 48th European Pancreatic Club Meeting

  • Published July 07, 2016 9:44AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

6th July 2017, ASX Announcement

OncoSil Medical Limited (ASX:OSL) (OncoSil Medical or the Company) a late stage medical device company focused on localised treatments for patients with pancreatic and liver cancer, today announced that a team of senior management would be attending the 48th European Pancreatic Club (EPC) in Liverpool, England.

The European Pancreatic Club meeting hosted by EPC President, Professor John Neoptolemos is focused entirely on pancreatic diseases and pancreatic cancer, making it one of the key international Scientific meetings for the Company to attend. This year the EPC meeting will run form 6 to 9 July 2016 and will host over 80 invited speakers from across Europe, the United States, Asia and Australia.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now